Update on Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease - 05/09/11
Résumé |
Early identification and intervention before the onset of symptomatic disease is the goal of management of chronic obstructive pulmonary disease (COPD).30, 79 Most patients with COPD need pharmacologic therapy. The judicious use of appropriate medications in a stepwise fashion is the recommended approach to treating patients with COPD and can improve airflows and provide significant symptomatic relief.2, 13, 30, 92 Patient response to treatment must be monitored and therapy should be customized for each individual.2, 13, 30, 92 Part of any successful pharmacologic intervention is patient education, including information related to medication dosing and timing, expected medication benefits, and potential side effects. Collaborative self management allows a well-educated patient to participate actively in his or her medical care. Anticipated outcomes from education include increased compliance with medication usage, earlier intervention during exacerbations, and, potentially, reduced health care costs owing to improved stability of disease.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Gary T. Ferguson, MD, Pulmonary and Critical Care Specialists, 28100 Grand River Avenue, Suite 306 N, Farmington Hills, MI 48336, e-mail: gferguson@botsford.org |
Vol 21 - N° 4
P. 723-738 - décembre 2000 Retour au numéro
Article précédent
- The Chronic Obstructive Pulmonary Disease Exacerbation
- Peter A. Sherk, Ronald F. Grossman
- Corticosteroids in Chronic Obstructive Pulmonary Disease : Clinical Benefits and Risks
- Charlene E. McEvoy, Dennis E. Niewoehner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?